Johns Hopkins Researchers Identify New Biological Target for Stopping Parkinson’s Disease Progression

Johns Hopkins Medicine study finds targeting the Aplp1 and Lag3 interaction could slow the progression of Parkinson’s and potentially treat other neurodegenerative diseases. Johns Hopkins...

from SciTechDaily https://ift.tt/bzW4mSK